The report contains ten-year analysis with the following sections
contact us for pricing
Check out our sample pages |
Many companies now available
Search to find companies of interest
read summary of their published patent
the company report contains more information
natco pharma | 389 |
natco pharma limited 'natco house | 1 |
nacto pharma | 1 |
natco pharma | 43 |
natco pharma | 25 |
Title of patent family (most common patent title) |
Family members |
Filing year |
---|---|---|
6.7-dialkoxy ouinazoline derivatives useful for treatment of cancer related disorders | 45 | 2008 |
formulation comprising phenylaminopyrimidine derivative as active agent | 42 | 2011 |
novel phenylaminopyrimidine derivatives as inhibitors of bcr-abl kinase | 25 | 2004 |
crystal form of phenylamino pyrimidine derivatives | 23 | 2004 |
novel pyrazolo [3, 4 -d] pyrimidine derivatives as anti -cancer agents | 23 | 2008 |
1h-1,8- naphthyridin-2ones as anti proliferative compounds | 21 | 2014 |
novel 4-(tetrazol-5-yl)-quinazoline derivatives as anti cancer agents | 20 | 2007 |
7-(morpholinyl)-2-(n-piperazinyl) methyl thieno [2, 3-c] pyridine derivatives as antican… 🛈 | 18 | 2014 |
use of (3-trifluoromethylsulfonyl)-n-[4-methyl -3-(4-pyridin-3-yl-pyrimidin-2yl-amino)-p… 🛈 | 17 | 2004 |
pharmaceutical compositions comprising phenylaminopyrimidine derivative | 12 | 2015 |